Lancet Neurology
The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three
Scientists identify early predictors of disease progression which could speed Huntington's disease drug trials
Scientists have identified a set of tests that could help identify whether and how Huntington's disease (HD) is progressing in groups of people who are not yet showing symptoms. The latest findings from the TRACK-HD study, ...
Neuroscience
May 08, 2013 |
not rated yet |
0
World-first study predicts epilepsy seizures in humans
A small device implanted in the brain has accurately predicted epilepsy seizures in humans in a world-first study led by Professor Mark Cook, Chair of Medicine at the University of Melbourne and Director of Neurology at St ...
Neuroscience
May 02, 2013 |
not rated yet |
0
|
Implanted device predicts epilepsy seizures in humans
For the first time, a small device implanted in the brain has accurately predicted the onset of seizures in some adults who have epilepsy that doesn't respond to drugs, according to a small proof-of-concept study published ...
Neuroscience
May 01, 2013 |
not rated yet |
0
Amyotrophic lateral sclerosis trial shows novel therapy is safe
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts ...
Neuroscience
Apr 23, 2013 |
not rated yet |
0
|
New genetic evidence suggests continuum among neurodevelopmental and psychiatric disorders
A paper published this month in the prestigious medical journal The Lancet Neurology suggests that a broad spectrum of developmental and psychiatric disorders, ranging from autism and intellectual disability to schizophrenia, should ...
Genetics
Apr 05, 2013 |
5 / 5 (2) |
0
Phase 1 ALS trial is first to test antisense treatment of neurodegenerative disease
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis (ALS) – blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease – may ...
Neuroscience
Apr 03, 2013 |
5 / 5 (1) |
0
|
Fetal exposure to antiepileptic drug valproate impairs cognitive development
(Medical Xpress)—The effects of antiepileptic drugs during pregnancy have long been a concern of clinicians and women of childbearing age whose seizures can only be controlled by medications. In 1999, a ...
Neuroscience
Mar 20, 2013 |
5 / 5 (1) |
0
|
Lithium shows no benefit to MND patients
(Medical Xpress)—Results from a clinical trial into amyotrophic lateral sclerosis (ALS), led by King's College London's Institute of Psychiatry show that lithium carbonate is ineffective at treating the ...
Neuroscience
Mar 19, 2013 |
5 / 5 (2) |
1
|
Sleepwalkers sometimes remember what they've done
Three myths about sleepwalking – sleepwalkers have no memory of their actions, sleepwalkers' behaviour is without motivation, and sleepwalking has no daytime impact – are dispelled in a recent study led by Antonio Zadra ...
Neuroscience
Mar 14, 2013 |
5 / 5 (1) |
0
New effort to identify Parkinson's biomarkers
Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers—changes in the body that can be used to predict, diagnose or monitor a disease—in ...
Parkinson's & Movement disorders
Mar 05, 2013 |
5 / 5 (1) |
0
Study finds parasites and poor antenatal care are main causes of epilepsy in Africa
The largest study of epilepsy in sub-Saharan Africa to date reveals that programmes to control parasitic diseases and access to better antenatal care could substantially reduce the prevalence of the disease in this region.
Neuroscience
Jan 30, 2013 |
not rated yet |
0
|
Study reveals long-term effects on child IQ of epilepsy drug valproate during pregnancy
Research published today in the Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.
Medications
Jan 22, 2013 |
not rated yet |
0
|
First Alzheimer's case has full diagnosis 106 years later
(Medical Xpress)—More than a hundred years after Alois Alzheimer identified Alzheimer's disease in a patient an analysis of that original patient's brain has revealed the genetic origin of their condition.
Alzheimer's disease & dementia
Jan 09, 2013 |
not rated yet |
0
|
Better stroke care, everywhere: Study boosts local hospitals' clotbuster use
From the moment a stroke occurs, patients must race against the clock to get treatment that can prevent lasting damage. Now, a new study shows the promise – and the challenges – of getting them state-of-the-art ...
Neuroscience
Dec 20, 2012 |
not rated yet |
0
|
Pediatric program for brain injuries saves lives, reduces disabilities
Children with traumatic brain injuries are more likely to survive and avoid long-term disabilities when treated aggressively as part of a designated neurocritical care program that brings together neurologists, ...
Neuroscience
Dec 13, 2012 |
not rated yet |
0
